MedPath

Pulmonary Tele-rehabilitation and Progressive Muscle Relaxation on Discharged Covid-19 Patients

Not Applicable
Completed
Conditions
Covid19
Interventions
Other: Pulmonary telerehabilitation
Other: progressive muscle relaxation training
Registration Number
NCT04741282
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

The aim of this study is to investigate efficacy of internet based pulmonary rehabilitation and progressive muscle relaxation program on functional capacity, depression and anxiety, dyspnea, fatigue, sleep quality and quality of life in covid19 patients after hospital discharge

Detailed Description

Novel coronavirus disease 2019 (covid19) could cause respiratory and physical dysfunction, anxiety and depression, fatigue and affect sleep quality and quality of life in infected patient after hospital discharge. there is expect that pulmonary rehabilitation can improve these symptoms and prevent complications in these cases. It seems that Progressive muscle relaxation exercise could improve pulmonary rehabilitation effect. Due to social isolation of Covid 19 patients after hospital discharge, internet base rehabilitation will be used in this study. participants will be randomized in two pulmonary tele-rehabilitation groups after hospital discharge. One group will be received pulmonary rehabilitation include education, breathing exercises, aerobic and upper and lower limbs muscle strengthening exercises. Another group will be perform progressive muscle relaxation in addition of these exercise. Treatment duration is 6 week with 5 days/week frequency. Two exercise sessions per week will be supervised with expert physiotherapist via videoconferencing.

Outcomes will be measured at baseline, within two week and at the end of six week exercises program.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Covid 19 patient that confirmed with polymerase chain reaction test (PCR)
  • Hospitalized Corvid 19 patients after discharge
  • Accessibility to internet and using video call
Read More
Exclusion Criteria
  • Mental and physical disability
  • Uncontrolled cardiac dysfunction such as arrhythmia
  • Sever neurological condition such as guillain-barre and stroke
  • Uncontrolled diabetes or blood pressure
  • Pregnant women
  • Re-hospitalization during treatment program
  • Chronic pulmonary and kidney condition
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
pulmonary telerehabilitationPulmonary telerehabilitationThis group will perform six week pulmonary rehabilitation program at theirs home, with two supervised sessions by physiotherapist per week via videoconferencing.
pulmonary telerehabilitation plus progressive muscle relaxation trainingprogressive muscle relaxation trainingThis group will perform six week pulmonary rehabilitation program and progressive muscle relaxation exercise at theirs home, with two supervised sessions by physiotherapist per week via videoconferencing.
pulmonary telerehabilitation plus progressive muscle relaxation trainingPulmonary telerehabilitationThis group will perform six week pulmonary rehabilitation program and progressive muscle relaxation exercise at theirs home, with two supervised sessions by physiotherapist per week via videoconferencing.
Primary Outcome Measures
NameTimeMethod
Functional capacitychange from baseline in 6MWT at 2 and 6 weeks

six minute walk test (6MWT)

Secondary Outcome Measures
NameTimeMethod
Sleep qualitychange from baseline in PSQI at 6 week

petersburg sleep quality index (PSQI), PSQI is a eighteen item scale.The total scores range is 0-21. A higher score indicates a worse sleep quality.

dyspneachange from baseline in Borg scale at 2 and 6 weeks

Borg scale, The borg scale is a self-rating tool to measure the degree of breathlessness on a scale from 0 to 10, higher score mean worse dyspnea

anxiety and depressionchange from baseline in HADS at 6 week

hospital anxiety and depression scale (HADS), HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression.The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety.

Trial Locations

Locations (1)

Iran university of medical sciences

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath